Treatment of irritable bowel syndrome with osteopathy: Results of a randomized controlled pilot study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 9, 2007, Pages 1394-1398

  Hundscheid, Henry W C ^a   Pepels, Manon J A E ^b   Engels, Leopold G J B ^b   Loffeld, Ruud J L F ^c  

^a Schinveld ^*  (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c ZAANS MEDICAL CENTER   (Netherlands)

Author keywords

Abdominal complaints; Irritable bowel syndrome; Osteopathy; Treatment

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL BOWEL DISORDER SEVERITY INDEX; HUMAN; IRRITABLE COLON; LIKERT SCALE; MALE; OSTEOPATHIC MEDICINE; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOM; VALIDATION STUDY;

EID: 34547986830     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04741.x     Document Type: Article

References (31)

1. Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment. Pharmacol. Ther. 1997 11 : 3 15.
2. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992 304 : 87 90.
3. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990 99 : 409 15.
4. Thompson WG. Irritable bowel syndrome: a management strategy. Baillière's Best Pract. Res. Clin. Gastroenterol. 1999 13 : 453 60.
5. Camilleri M. Review article: clinical evidence to support current therapies of irritable bowel syndrome. Aliment. Pharmacol. Ther. 1999 13 (Suppl. 2 48 53.
6. Spiller RC. Potential future therapies for irritable bowel syndrome: will disease modifying therapy as opposed to symptomatic control become a reality? Gastroenterol. Clin. North Am. 2005 34 : 337 54.
7. Kim HJ, Callimeri M, McKinzie S et al. A randomised controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2003 17 : 895 904.
8. Nobaet S, Johansson ML, Molin G, Ahne S, Jeppson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J. Gastroenterol. 2000 95 : 1231 8.
9. Simren M, Ringstrom G, Bjornsson ES, Abrahansson H. Treatment with hypnotherapy reduces the sensory motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom. Med. 2004 66 : 233 8.
10. Palsson OS, Turner MJ, Johnson DA, Burnett CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig. Dis. Sci. 2002 47 : 2605 14.
11. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am. J. Gastroenterol. 1996 91 : 277 83.
12. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999 45 (Suppl. II 1 5.
13. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. BMJ 1978 2 : 653 4.
14. Gezondheidsraad: Commissie Alternatieve Behandelwijzen. Alternatieve behandelwijzen en wetenschappelijk onderzoek. Publication number 1993/13. Den Haag : Gezondheidsraad, 1993.
15. Hahn BA, Kirchdörfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 1997 11 : 547 52.
16. Drossman DA. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am. J. Med. 1999 107 (Suppl. 41 50.
17. Drossman DA, Li Z, Toner BB et al. Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig. Dis. Sci. 1995 40 : 986 95.
18. Becker RE. Life in motion: the osteopathic vision of Rollin E Becker, DO. Portland : Stillness Press, 1997.
19. Hoste R. Osteopathie en wetenschappelijk onderzoek Thesis for the National Belgian Society of Osteopathy, 2000.
20. Howell JD. The paradox of osteopathy. N. Engl. J. Med. 1999 341 : 1465 8.
21. Riot FM, Goudet P, Mouraux JP, Cougard P. Levator ani syndrome, functional intestinal disorders and articular abnormalities of the pelvis, the place of osteopathic treatment. Presse. Med. 2004 33 : 852 7.
22. Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am. J. Med. 1999 107 : 91S 97S.
23. Veldhuyzen van Zanten SJO, Talley NJ, Bytzer P et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999 45 (Suppl. II 69 77.
24. Gaynes BN, Drossman DA. The role of psychosocial factors in irritable bowel syndrome. Baillière's Best Pract. Res. Clin. Gastroenterol. 1999 13 : 437 52.
25. Aziz Q, Thompson DG. Brain-gut axis in health and disease. Gastroenterology 1998 114 : 559 78.
26. Wood JD, Alpers DH, Andrews PLR. Fundamentals of neurogastroenterology. Gut 1999 45 (Suppl. II 6 16.
27. Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment. Pharmacol. Ther. 1999 13 (Suppl. 2 15 30.
28. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990 99 : 1688 704.
29. Camilleri M, Ford MJ. Functional gastrointestinal disease and the autonomic nervous system: a way ahead? Gastroenterology 1994 106 : 1114 18.
30. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994 107 : 271 93.
31. Mach T. The brain-gut axis in irritable bowel syndrome - clinical aspects. Med. Sci. Monit. 2004 10 : 125 31.